Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Investing Activities: 2017-2024

Historic Cash from Investing Activities for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $38.3 million.

  • Cogent Biosciences' Cash from Investing Activities was N/A to -$433,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.4 million, marking a year-over-year change of. This contributed to the annual value of $38.3 million for FY2024, which is 139.13% up from last year.
  • As of FY2024, Cogent Biosciences' Cash from Investing Activities stood at $38.3 million, which was up 139.13% from -$97.8 million recorded in FY2023.
  • In the past 5 years, Cogent Biosciences' Cash from Investing Activities ranged from a high of $38.3 million in FY2024 and a low of -$124.7 million during FY2022.
  • In the last 3 years, Cogent Biosciences' Cash from Investing Activities had a median value of -$97.8 million in 2023 and averaged -$61.4 million.
  • Per our database at Business Quant, Cogent Biosciences' Cash from Investing Activities plummeted by 7,155.26% in 2022 and then surged by 139.13% in 2024.
  • Yearly analysis of 5 years shows Cogent Biosciences' Cash from Investing Activities stood at $8.4 million in 2020, then slumped by 120.42% to -$1.7 million in 2021, then crashed by 7,155.26% to -$124.7 million in 2022, then rose by 21.56% to -$97.8 million in 2023, then soared by 139.13% to $38.3 million in 2024.